Answers are grounded in this paper and cite their sources.
Artificial metalloenzymes based on biotin-streptavidin technology, a "fusion" of chemistry and biology, illustrate how asymmetric catalysts can be improved and evolved using chemogenetic approaches.
No takes yet. Share an insight, caveat, or question.
Creus et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: